| KMDVX | VMVAX | KMDVX / VMVAX | |
| Total Expense Ratio | 1.20 | 0.07 | 1,714% |
| Annual Report Gross Expense Ratio | 1.41 | 0.07 | 2,014% |
| Fund Existence | 14 years | 14 years | - |
| Gain YTD | 8.253 | 8.872 | 93% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 127M | 31.8B | 0% |
| Annual Yield % from dividends | 1.01 | 2.20 | 46% |
| Returns for 1 year | -3.64 | 2.82 | -129% |
| Returns for 3 years | 21.08 | 26.82 | 79% |
| Returns for 5 years | 54.92 | 56.57 | 97% |
| Returns for 10 years | 100.23 | 108.57 | 92% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CPOCX | 19.70 | N/A | N/A |
| Morgan Stanley Insight L | |||
| FIQWX | 18.50 | N/A | N/A |
| Fidelity Advisor Strategic Div & Inc Z | |||
| VVIEX | 14.74 | -0.14 | -0.94% |
| VOYA VACS Index Series EM Portfolio | |||
| CSDGX | 15.36 | -0.20 | -1.29% |
| Copeland SMID Cap Dividend Growth A | |||
| LIAGX | 17.14 | -0.33 | -1.89% |
| Lord Abbett International Growth I | |||